Innovation Pharmaceuticals Inc (IPIX)

[Yooper61]

Your guess may as be as good as mine, but your logic is not. If they broke the blind or not, whatever data they had on 6 week results, they also had on patients that completed 12 weeks. That’s a fact. Explain how a Michigan MBA and a demonstrated frugal CPA could look at the data, not report on 6 week data and proceed to spend $3.3M? TIAB has not answered this question, perhaps you might give it a try?